Madeeha Drissi, | |
2401 S 31st St # Ms 01161b, Temple, TX 76508-0001 | |
(254) 771-8100 | |
Not Available |
Full Name | Madeeha Drissi |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 2401 S 31st St # Ms 01161b, Temple, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437716057 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 75745 (Minnesota) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Madeeha Drissi, 2401 S 31st St Bldg 27, Temple, TX 76508-0001 Ph: (214) 909-7519 | Madeeha Drissi, 2401 S 31st St # Ms 01161b, Temple, TX 76508-0001 Ph: (254) 771-8100 |
News Archive
Women with a longer reproductive period had an elevated risk for dementia in old age, compared with those who were fertile for a shorter period, a population-based study from the University of Gothenburg shows.
The dynamics of the current COVID-19 pandemic could offer valuable insights for the efforts to mitigate climate change.
Will the day come when cracks in buildings close up without external help and before they get to the stage where they cause damage to the component?
ViroLogic announced today that it had entered into an agreement with AstraZeneca to conduct a cancer biomarker study with application to Iressa, AstraZeneca's selective epidermal growth factor receptor kinase inhibitor.
› Verified 3 days ago